Cefuroxime Dose Adjustment in CKD Stage 5
Cefuroxime dosing requires adjustment based on creatinine clearance (CrCl) because cefuroxime is primarily renally eliminated. [1] For CKD stage 5 with severe renal impairment (commonly corresponds to CrCl <10 mL/min), dosing intervals are extended. [1]
Dosing for Cefuroxime Axetil Tablets (Oral)
For adults with severe renal impairment, the prescribing information for cefuroxime axetil tablets provides CrCl-based interval adjustments. [1]
- CrCl <10 mL/min (without hemodialysis): standard individual dose given every 48 hours. [1]
- Hemodialysis: a single additional standard dose should be given at the end of each dialysis. [1]
Dosing for Cefuroxime (Zinacef) Injection (IV/IM)
For adults with reduced renal function, the prescribing information for ZINACEF provides CrCl-based frequency adjustments. [2]
- CrCl <10 mL/min: 750 mg every 24 hours. [2]
- Hemodialysis: a further dose should be given at the end of dialysis (because ZINACEF is dialyzable). [2]
Clinical Clarification Required for Correct Dose Selection
The exact prescribed regimen depends on the formulation (cefuroxime axetil tablets vs ZINACEF injection), the patient’s CrCl, and whether the patient is on hemodialysis. [1], [2]
Common Documentation Gap in CKD Stage 5 Dosing
CKD stage 5 may be documented without specifying CrCl and dialysis status, which are required to select the correct cefuroxime dosing interval from labeling tables. [1], [2]